2021 Scientific Sessions

Cath Lab Boot Camp

Abstract Session L: Quality Improvement
Utilization of Sex-Specific Reporting to Assess Disparities in Percutaneous Coronary Intervention Related Process Measures
Julia L. Berkowitz, M.D.
Changing Landscape of Interventional Cardiology Practice in COVID-19 Era: A Middle Eastern Perspective
Zainab Atiyah Dakhil, FIBMS Cardiol
30-Days readmission after percutaneous coronary intervention (PCI) with drug-eluting stents (DES) in patients with active cancer: Outcomes and predictors.
Juan Del Cid Fratti MD MS, MD MSc
The Impacts of COVID-19 on Veterans Affairs Catheterization Laboratory Staff During the First Six Months of the US Response: A National Mixed-Methods Study
Heather Gilmartin, PhD
Evaluating Outcomes in Very Elderly Patients Undergoing Revascularization for Stable Ischemic Heart Disease Stratified by Racial/Ethnic Group
Derek Q. Phan, M.D.
Digitally Transmitted ECG’s Viewed on a Large Screen Does Not Improve Correct STEMI Diagnosis Compared to Print/Scan/Fax ECG’s Viewed on a Handheld device
Natali Sorajja, BA
Coronary Angiography and Frailty: What do interventionalists and patients decide?
Jeffrey Taylor, DO
Ongoing Review is Necessary for Maintaining Quality
Bonnie H. Weiner, M.D. MSEC MBA, MSCAI
Algorithms for the Cath Lab: How to Apply to the Individual Patient
Ambulatory PCI
Welcoming Remarks
Lyndon Carlos Box, M.D., FSCAI
The Rationale for Ambulatory PCI
Arnold H. Seto, MD, MPA, FSCAI
What Defines an ASC and What Procedures Can I Do?
Peter L. Duffy, M.D., FSCAI
How to Ensure Quality in the ASC Setting
Faisal Latif, M.D., FSCAI
Reimbursement and Coding for ASC Procedures
Yazan Khatib, M.D., FSCAI
Lessons Learned From Starting an ASC
Tony Das, M.D., FSCAI
Discussion
Being the Best We Can Be
Best of the Tip of the Month
Cath Lab Microeconomics and Macroeconomics
Clinical Cases That Challenge Ethical Boundaries
Case Presentation: To DO or Not to DO – Stenting in Patients With Uncertain Adherence and Financial Limitations
Mark Kardos Tuttle, M.D.
Commentary: To DO or Not to DO – Stenting in Patients With Uncertain Adherence and Financial Limitations
Donald E. Cutlip, M.D., FSCAI
Case Presentation and Commentary: Utility vs. Futility – TTVR for Recurrent IVDU-Associated Endocarditis
Lee Eschenroeder, MD, James Kirkpatrick, MD
Case Presentation and Commentary: When Does Cognitive Impairment or Frailty Preclude the Benefit From TAVR?
Diana Carolina Otero Mostacero, MD, Megan Coylewright, M.D., FSCAI
Case Presentation: Difficult Decisions in Adults With Advanced Congenital Heart Disease?
Graham Bevan, MD
Commentary: Difficult Decisions in Adults With Advanced Congenital Heart Disease?
Jill Steiner, MD
Dual and Triple Therapy in the PCI Patient: A Moving Target
Health and Safety in the Cath Lab
High-Risk Scenarios and Prevention of Complications
Quality Improvement Tools